Zanubrutinib in AL Amyloidosis Associated With Waldenström Macroglobulinemia and Other B-Cell Non-Hodgkin Lymphoma - PubMed
6 hours ago
- #B-Cell Non-Hodgkin Lymphoma
- #AL Amyloidosis
- #Zanubrutinib
- Zanubrutinib is studied in AL amyloidosis associated with Waldenström macroglobulinemia and other B-cell non-Hodgkin lymphomas.
- The study is published with PMID: 41837358 and DOI: 10.1002/ajh.70267.
- The article includes details on publication types, grants, funding, and full-text sources.